Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study is to compare the pharmacokinetics (how the body absorbs, breaks down and eliminates drug from your body) of nalmefene when given as a single dose intranasally (IN;into the nose), as a single dose in each nostril and as two doses in one nostrils; and to evaluate the safety and tolerability of nalmefene IN.
Epistemonikos ID: fc127788b22182fdc50ecc631ea814a7adde4561
First added on: May 10, 2024